Standard

PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA. / Kolbin, A; Frolov, M; Kurylev, A; Balykina, Y; Proskurin, M.

в: Value in Health, № 3:19-29, 2015.

Результаты исследований: Научные публикации в периодических изданияхстатья

Harvard

APA

Vancouver

Author

BibTeX

@article{f8bcc71d8d7d4578aa7df348aacefc1b,
title = "PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA",
author = "A Kolbin and M Frolov and A Kurylev and Y Balykina and M Proskurin",
year = "2015",
language = "не определен",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier",
number = "3:19-29",

}

RIS

TY - JOUR

T1 - PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

AU - Kolbin, A

AU - Frolov, M

AU - Kurylev, A

AU - Balykina, Y

AU - Proskurin, M

PY - 2015

Y1 - 2015

M3 - статья

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 3:19-29

ER -

ID: 5829193